The Ethics of Psychological Artificial Intelligence: Clinical Considerations

2021 ◽  
Vol 66 (2) ◽  
pp. 131-144
Author(s):  
Russell Fulmer ◽  
Tonya Davis ◽  
Cori Costello ◽  
Angela Joerin
2020 ◽  
pp. bjophthalmol-2019-315651 ◽  
Author(s):  
Darren Shu Jeng Ting ◽  
Valencia HX Foo ◽  
Lily Wei Yun Yang ◽  
Josh Tjunrong Sia ◽  
Marcus Ang ◽  
...  

With the advancement of computational power, refinement of learning algorithms and architectures, and availability of big data, artificial intelligence (AI) technology, particularly with machine learning and deep learning, is paving the way for ‘intelligent’ healthcare systems. AI-related research in ophthalmology previously focused on the screening and diagnosis of posterior segment diseases, particularly diabetic retinopathy, age-related macular degeneration and glaucoma. There is now emerging evidence demonstrating the application of AI to the diagnosis and management of a variety of anterior segment conditions. In this review, we provide an overview of AI applications to the anterior segment addressing keratoconus, infectious keratitis, refractive surgery, corneal transplant, adult and paediatric cataracts, angle-closure glaucoma and iris tumour, and highlight important clinical considerations for adoption of AI technologies, potential integration with telemedicine and future directions.


2020 ◽  
Author(s):  
Glen Cheng ◽  
Nischal Chennuru ◽  
Liz Kwo

This chapter will introduce the clinician to the quickly expanding field of musculoskeletal-focused digital apps (MDA), with an eye towards helping the clinician select and recommend MDAs for optimal patient care. MDAs are increasingly being used for physical therapy and rehabilitation, telehealth, pain management, behavioral health, and remote patient monitoring. The COVID-19 pandemic has vastly accelerated the adoption of telehealth and digital health apps by patients and clinicians, and the digital health field will only continue to expand as developers increasingly harness artificial intelligence (AI) and machine learning (ML) capabilities, coupled with precision medicine capabilities that integrate personal health data tracking and genomics insights. Here we begin with an overview of several types of MDA, before discussing the epidemiology of musculoskeletal conditions and injuries, clinical considerations in selecting a digital health solution, payor reimbursement for digital apps, and regulatory oversight of digital health apps.


Author(s):  
David L. Poole ◽  
Alan K. Mackworth

Sign in / Sign up

Export Citation Format

Share Document